GNE‐317 Reverses MSN‐Mediated Proneural‐to‐Mesenchymal Transition and Suppresses Chemoradiotherapy Resistance in Glioblastoma via PI3K/mTOR
Advanced Science · 2025
DOI: 10.1002/advs.202412517 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Yong-Chang Yang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Can…. Hauptthemen laut MEDLINE: Glioblastoma, TOR Serine-Threonine Kinases, Brain Neoplasms, Imidazoles. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Tianjin Education Commission scientific research plan general project, Tianjin Municipal Transportation Commission Science and Technology Development Plan Project.
Abstract (Originalsprache)
Glioblastoma (GBM) resistance to chemoradiotherapy is a major factor contributing to poor treatment outcomes. This resistance markedly affects the effectiveness of surgery combined with chemoradiotherapy and leads to post‐surgical tumor recurrence. Therefore, exploring the mechanisms underlying chemoradiotherapy resistance in GBM is crucial for understanding its progression and improving therapeutic options. This study found that moesin (MSN) acts as a key promotor of chemoradiotherapy resistance in glioma stem cells (GSCs), enhancing their proliferation and stemness maintenance. Mechanistically, MSN activates the downstream PI3K/mTOR signaling pathway, driving the proneural‐to‐mesenchymal transition (PMT) in GSCs. This process enhances the repair of DNA damage caused by radiotherapy (RT) and temozolomide (TMZ), thereby increasing the resistance of GSCs to chemoradiotherapy. Additionally, GNE‐317, a small molecule drug capable of crossing the blood‐brain barrier, specifically inhibits MSN and suppresses the activation of downstream PI3K/mTOR signaling. Importantly, the combination of GNE‐317 with RT and TMZ exhibits a strong synergistic effect both in vivo and in vitro, achieving better efficacy compared to the traditional combination of RT and TMZ. This study not only advances understanding of the mechanisms underlying chemoradiotherapy resistance in GBM but also provides a promising new approach for enhancing treatment outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin…
- Tianjin Medical University, Tianjin, 300060, P. R. China.
- Beijing Neurosurgical Institute, Capital Medical University, Beijing, 100054, P. R. China.
- Department of Neuro-Oncology and Neurosurgery, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, 300060, P.…
ORCID-Profile: Yong-Chang Yang, Xun Jin
Förderung
- National Natural Science Foundation of China
- Tianjin Education Commission scientific research plan general project
- Tianjin Municipal Transportation Commission Science and Technology Development Plan Project
Zitieren
APA
Yang, Y. C., Jin, X. Y., Yang, L. L., Xu, X., Xie, Y., Ai, Y. D., Li, X. C., Ma, Y. C., Xu, C. L., Li, Q., Ge, X. L., Yi, T. L., Jiang, T., Wang, X. G., Piao, Y. Z., & Jin, X. (2025). GNE‐317 Reverses MSN‐Mediated Proneural‐to‐Mesenchymal Transition and Suppresses Chemoradiotherapy Resistance in Glioblastoma via PI3K/mTOR. Advanced Science. https://doi.org/10.1002/advs.202412517
Vancouver
Yang YC, Jin XY, Yang LL, Xu X, Xie Y, Ai YD, et al. GNE‐317 Reverses MSN‐Mediated Proneural‐to‐Mesenchymal Transition and Suppresses Chemoradiotherapy Resistance in Glioblastoma via PI3K/mTOR. Advanced Science. 2025. doi:10.1002/advs.202412517
BibTeX
@article{Yang2025,
author = {Yang, Yong-Chang and Jin, Xing-Yu and Yang, Ling-Ling and Xu, Xing and Xie, Yang and Ai, Yi-Ding and Li, Xin-Chao and Ma, Ye-Cheng and Xu, Cheng-Long and Li, Qi and Ge, Xiang-Lian and Yi, Tai-Long and Jiang, Tao and Wang, Xiao-Guang and Piao, Ying-Zhe and Jin, Xun},
title = {GNE‐317 Reverses MSN‐Mediated Proneural‐to‐Mesenchymal Transition and Suppresses Chemoradiotherapy Resistance in Glioblastoma via PI3K/mTOR},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202412517}
}
EUVIMED